Scientists Win Asturias Research Prize

Why this is here: Next-generation sequencing now costs roughly $1,000 and takes one day, a stark contrast to the ten years and over $1 billion required to sequence the human genome in 2000.

British chemists David Klenerman and Shankar Balasubramanian, along with French biophysicist Pascal Mayer, receive the 2026 Princess of Asturias Award for Research in Spain. The three scientists pioneered next-generation DNA sequencing technology. They invented a method to quickly and affordably sequence DNA on a large scale.

Klenerman and Balasubramanian, both professors at the University of Cambridge, co-founded Solexa-Illumina to make their technology widely available. Mayer later joined, contributing discoveries that furthered the development of the technology. The process involves breaking DNA into small fragments, immobilizing them on a chip, and decoding them with a computer program.

This technique reduces genome sequencing time to one day at an approximate cost of $1,000. Sequencing the human genome took ten years and over $1 billion in 2000.

The technology aids cancer diagnosis, rare disease research, and prenatal testing. While crucial in identifying new coronavirus strains and aiding vaccine development, the article does not detail the long-term impacts or potential drawbacks of widespread genomic data. Further research will continue to refine and expand these applications.